Re-registration of Augentrofen Stulln Mono Eye-drops (Esculin and Digtalisglycosides Eye-Drops) has been approved by the China Food and Drug Administration (“CFDA”) that Augentrofen Stulln Mono Eye-drops gained a new Imported Drug License with the term of 5 years.
The successful renewal of Imported Drug License of Augentrofen Stulln Mono Eye-drops provides the drug with legal protection and legal support to achieve sustainable sales growth of the drug in the China market.